Tuberculosis Essay

Tuberculosis has long been a disease that the human culture has been dealing with which entails significant morbidity and mortality worldwide. With dealing with such a horrific disease over the years, discoveries and evolution on the appropriate ways to contain, diagnose, and challengingly treat the disease has changed. One of the most concerning complications of this worldwide public health issue is the ability for it to quickly spread in high populated areas while becoming ever more resistant to forms of treatment not available in all locations around the world. This is a serious public

Now, scientists are warning signs of risks of tuberculosis and share information about bacterias and viruses. Today, when a new germ is known, they have a better chance of learning how to cure and fight it. Volunteers take the time to help in laborites in the United States, South America, Central America, and Asia. The World Health Organization reports that third of the world’s population is infected and eight million people get sick from tuberculosis that is identified to be helped by medicine from spreading the disease to

Tuberculosis is a disease of an infectious nature caused by a bacterium known as mycobacterium tuberculosis. The disease spreads through the air. People with the disease can spread it to susceptible people through coughing, sneezing, talking or spitting. It mainly affects the lungs and other parts such as the lymph nodes and kidneys can also be affected. The symptoms for TB are fatigue, coughing, night sweats, weight loss and fever. One third of the population of the world is affected with mycobacterium tuberculosis. The rate of infection is estimated to be one person per second. About 14 million people in the world are infected with active tuberculosis. Drug resistant TB has been recorded to be a serious public health hazard in many countries. Resistant strains have developed making it difficult to treat the disease. TB has caused millions of death mainly in people living with HIV/AIDS ADDIN EN.CITE Ginsberg19981447(Ginsberg, 1998)1447144717Ginsberg, Ann M.The Tuberculosis Epidemic: Scientific Challenges and OpportunitiesPublic Health Reports (1974-)Public Health Reports (1974-)128-13611321998Association of Schools of Public Health00333549http://www.jstor.org/stable/4598234( HYPERLINK l "_ENREF_3" o "Ginsberg, 1998 #1447" Ginsberg, 1998). The World Health Organization came up with the DOTS (Directly Observed, Therapy, Short course) strategy. The approach involves diagnosing cases and treating patients with drugs for about 6-8

Once believed to be easily treated and prevented, Tuberculosis (TB) has recently been making a steady comeback. Previous to modern medicine, TB claimed millions of victims, spreading from person to person like wildfire. Around the 17th-18th centuries, the “White Plague” took the lives of 1 in 5 adults (20%) in Europe and North America (Iseman, 1994). However, as technological advances progressed, this seemingly ferocious viral disease became a primal, insignificant thing of the past. But, in the nature of all bacteria, TB has, in the recent years, mutated to become progressively drug resistant. Why is Tuberculosis coming back with a vengeance? Well, the answer’s quite simple. TB has done an amazing job of standing in the corner and

According to the World Health Organization, tuberculosis (TB) is the number two killer worldwide due to a single infectious agent (WHO, 2017). In 2015, 10.4 million new cases have been identified and 1.8 million people have died from this disease (WHO, 2017). TB is caused by the bacteria Mycobacterium TB, and the majority of TB deaths occur in low and middle-income countries. This disease is curable and preventable, but the lack of access to proper healthcare and medication administration makes it a concern for the most of the world’s population. TB is an airborne disease that can transmit when an infected person coughs, sneezes, spits, laughs, or talks. The majority of TB cases can be cured when the right medications are available and

Among many misconceptions, tuberculosis is not a disease of the past. Tuberculosis remains a public health issue. It is estimated that one-third of the total world population is infected by tuberculosis (TB). The American lung association (2013) states, in 2011 alone there were nearly 9,000,000 new diagnosed cases of tuberculosis around the world and an estimated 1.4 million deaths because of this disease. In the United States, TB is not as common (but still a problem). In 2011, only 10,500 people reported having TB (Trends in Tuberculosis Morbidity and

Often times, people in third world countries face health problems that are not experienced in first and second world countries. Diseases that do not exist in the countries such as the US anymore are still some of the leading problems in poor nations. Professor Susan Craddock from the department of Gender, Woman and Sexuality studies gave a presentation that focused on Tuberculosis, which is falls into a category of diseases called “neglected diseases”. They are called neglected because the development of vaccines and drugs to cure the diseases has decreased to about nothing. The market for these drugs is not lucrative enough for pharmaceutical companies in higher income countries to invest in research. Since the low income countries do not have the resources to carry out research for these drugs the number of neglected disease-related deaths has increased. I found the presentation interesting and enlightening especially because I am interested in the pharmaceutical field. In response to the neglected diseases, different organizations have come together to research and develop vaccines and drugs that can treat these diseases.

Tuberculosis (Mycobacterium tuberculosis), also known as TB, is a disease spread by respiratory inhalation of droplets that contain the bacteria. Tuberculosis is an ancient disease that has been traced back at least 9000 years. In 1882, Dr. Robert Koch was the first physician to describe Mycobacterium tuberculosis as the germ responsible for tuberculosis. However, treatment that was evidenced based was not put into practice until the 20th century. It is estimated that 2 billion people around the world are infected with the TB bacteria. Approximately 5 to 10 percent of these infected people will actual develop active TB and experience the life-threatening symptoms of the disease. Tuberculosis

Tuberculosis is a disease cause by a bacterium that spreads when a person infected with the virus, sneezes, coughs, or even talks and the germs make it into the air for another person to breathe. This bacterium primarily affects the lungs and prevents the proper functioning of the respiratory system. Tuberculosis continues to be a problem in the United States and the problem is even bigger in developing countries such as India where they have seen the growth of MDR-TB cases. The following annotated bibliographies include a variety of peer review journals, a CDC website and the RX for survival video, which addresses the burden of tuberculosis in different parts of the world. The bibliographies also look at the risk factors, prevalence, mortality,

Despite the accessibility of inexpensive and successful treatment, tuberculosis still accounts for millions of cases of active disease and deaths worldwide. The disease unreasonably has an effect on the neediest persons in both high-income and developing countries. However, recent improvements in diagnostics, drugs, vaccines and enhanced implementation of present interventions have increased the outlooks for enhanced clinical care and global tuberculosis restriction.

In an era where we consider the improvement of technology as the key to overcoming most a finding of diseases. Tuberculosis disease has been in existence for years; the ancient plague of tuberculosis continues to spread throughout population and countries. Beyond any other infectious disease. “In 2013, 9 million people around the world became sick with TB disease. There were around 1.5 million TB-related deaths worldwide (Kim, Shakow, Castro, Vande, & Farmer, 2015).” With all the technology improvement and drugs we still struggle to manage this deadly disease. Between 18th and19th century tuberculosis spread and reaches its maximal growth in urban and industrial environment of the united states and Europe. During that time in the Western

The world health organisation (WHO) (2015b) reports that 95% of these deaths are in resource poor areas. This essay will focus on Sub-Saharan Africa, an area with a wide proportion of resource poor settings. WHO (2015d) estimated around 3.2million people in Africa to have TB, with a mortality rate of 450,000. Ethiopia, Kenya, Tanzania, Uganda and the Democratic Republic of the Congo were in the top 25 countries in the

“Despite all the ghastliness in the world, human beings are made for goodness, the ones that held in high regard are not militarily powerful nor economically prosperous. They have a commitment to try and make the world a better place” (Desmond Tutu,15)- Archbishop Desmond Tutu. Strong words of hope and faith in humanity come from a man who is regarded in the same heights as Ghandi. Archbishop Desmond Tutu is a survivor of the deadly disease known as, Tuberculosis. According to the CDC, “One third of the world’s population is infected with TB” . A staggering number, but the amount of deaths from TB is even more astonishing, “1.8 million deaths in 2015” (Center for Disease Control). Most people get confused with what exactly tuberculosis even is, whether people say it’s like the flu or bronchitis, but it’s something truly life threatening. Tuberculosis is not exclusive to only one race, ethnicity, or gender, tuberculosis is able to kill anyone regardless of age. Therefore, it is important to raise awareness and educate all the people in the world of the Tuberculosis.

Although Africa and other developing nations lead in the number of those infected with tuberculosis, the infected population in the world is currently estimated to be at around one third of the

In 2011, WHO estimated 12 million prevalent cases of tuberculosis worldwide, of which about 630 000 (roughly 5%) were MDR tuberculosis. The highest caseloads of MDR tuberculosis were reported in India, China, Russia, and South Africa, which accounted for more than 60% of cases worldwide. India and China have the highest number of MDR tuberculosis cases worldwide. Tuberculosis has now been made a notifiable disease in India. Drug resistance surveys in several states have indicated that the prevalence of MDR TB in India is 2–3 percent among new cases and 12-17 percent among reinfection cases. According to drug